Cita APA

Chulanetra, M., Morchang, A., Sayour, E., Eldjerou, L., Milner, R., Lagmay, J., . . . Chang, L. (2020). GD2 chimeric antigen receptor modified T cells in synergy with sub-toxic level of doxorubicin targeting osteosarcomas. Am J Cancer Res.

Chicago Style Citation

Chulanetra, Monrat, et al. "GD2 Chimeric Antigen Receptor Modified T Cells in Synergy With Sub-toxic Level of Doxorubicin Targeting Osteosarcomas." Am J Cancer Res 2020.

Cita MLA

Chulanetra, Monrat, et al. "GD2 Chimeric Antigen Receptor Modified T Cells in Synergy With Sub-toxic Level of Doxorubicin Targeting Osteosarcomas." Am J Cancer Res 2020.